Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Afrezza
Afrezza
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
MannKind: Small step for delivery tech R&D after Afrezza's giant leap
In-Pharma Technologist
Mon, 01/19/15 - 04:06 pm
R&D
MannKind
Afrezza
drug delivery
Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger
Yahoo/Benzinga
Mon, 01/12/15 - 07:30 pm
MannKind
R&D
Afrezza
diabetes
M&A
Sanofi
MannKind Gets Little Love From Sanofi at 'JPM15' Presentation
TheStreet.com
Mon, 01/12/15 - 03:34 pm
MannKind
diabetes
Sanofi
Afrezza
inhaled insulin
JPMHC 2015
History Suggests MannKind Corporation's Afrezza Could Already Be Doomed
Motley Fool
Fri, 01/9/15 - 08:30 am
MannKind
Afrezza
inhaled insulin
insulin
diabetes
drug pricing
Can MannKind Corporation Stock Soar in 2015?
Motley Fool
Wed, 12/31/14 - 08:54 am
MannKind
Afrezza
insulin
inhaled insulin
Is MannKind Corporation in Bed With Crooks? And Should Investors Care?
Motley Fool
Fri, 12/12/14 - 08:45 am
MannKind
Sanofi
Afrezza
Mannkind Reality Check Redux: 82.4 Million Reasons To Leave Your Lover!
Seeking Alpha
Tue, 12/9/14 - 07:57 am
MannKind
Sanofi
diabetes
Afrezza
Losing Confidence In MannKind
Seeking Alpha
Fri, 12/5/14 - 10:57 am
MannKind
Afrezza
diabetes
Will Insulin Pricing Be MannKind Corporation's Downfall?
Motley Fool
Wed, 11/26/14 - 12:11 pm
MannKind
diabetes
insulin
inhaled insulin
Afrezza
drug pricing
MannKind’s Afrezza Remains in Sanofi’s Plans, RBC Says
Barron's
Fri, 11/21/14 - 03:07 pm
MannKind
inhaled insulin
Afrezza
diabetes
Sanofi
Is this MannKind Corporation's Worst Nightmare?
Motley Fool
Mon, 11/10/14 - 09:46 am
MannKind
Afrezza
diabetes
reimbursement
Why Is Sanofi Betting on MannKind Corporation's Afrezza?
Motley Fool
Mon, 10/6/14 - 10:57 am
Sanofi
MannKind
diabetes
Afrezza
MannKind Receives $150 Million Upfront Payment from Sanofi
Yahoo/Zacks.com
Fri, 10/3/14 - 04:28 pm
MannKind
Sanofi
Afrezza
MannKind and Sanofi Complete Afrezza Collaboration Deal
Yahoo/Zacks
Sat, 09/27/14 - 10:11 am
MannKind
Sanofi
Afrezza
diabetes
type 2 diabetes
Sanofi, MannKind say cutting insulin costs will make Afrezza more competitive
Fierce Pharma Marketing
Wed, 09/17/14 - 05:47 pm
Sanofi
MannKind
insulin
diabetes
Afrezza
What the Market is Telling MannKind
24/7 Wall St
Wed, 08/13/14 - 10:20 am
MannKind
Afrezza
insulin
inhaled insulin
Sanofi
Did MannKind Find Right Afrezza Partner in Sanofi?
Barron's
Tue, 08/12/14 - 05:31 pm
MannKind
Afrezza
Sanofi
diabetes
inhaled insulin
insulin
Most Popular News Headlines For Monday, August 11 2014
CP Wire
Tue, 08/12/14 - 09:13 am
Celltrion
Remsima
Jannsen
Remicade
Invokamet
JNJ
Sanofi
Cologuard
MannKind
Afrezza
EXACT Sciences
Most popular news headlines for Monday, August 11 2014
Tue, 08/12/14 - 09:07 am
Celltrion
Remsima
Jannsen
Remicade
Invokamet
JNJ
Sanofi
Cologuard
MannKind
Afrezza
EXACT Sciences
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »